Literature DB >> 15598775

Testicular cancer incidence in eight northern European countries: secular and recent trends.

Lorenzo Richiardi1, Rino Bellocco, Hans-Olov Adami, Anna Torrång, Lotti Barlow, Timo Hakulinen, Mati Rahu, Aivars Stengrevics, Hans Storm, Steinar Tretli, Juozas Kurtinaitis, Jerzy E Tyczynski, Olof Akre.   

Abstract

OBJECTIVE: Striking geographic variation and marked increasing secular trends characterize the incidence of testicular cancer. However, it is not known whether these patterns have attenuated in recent years and whether they are similar for seminomas and nonseminomas, the two main histologic groups of testicular cancer.
METHOD: Cancer registry data, including 27,030 testicular cancer cases, were obtained from Denmark, Estonia, Finland, Latvia, Lithuania, Norway, Poland, and Sweden. Between 57 (Denmark) and 9 (Poland) years of registration were covered. Country-specific temporal trends were estimated, with focus on the last decade and seminomas and nonseminomas. Data from the Nordic countries were further analyzed using an age-period-cohort approach.
RESULTS: Age-standardized incidence rates increased annually by 2.6% to 4.9% during the study period, with marginal differences between seminomas and nonseminomas. In the last decade, the increasing trend attenuated only in Denmark (annual change, -0.3%; 95% confidence interval, -1.5 to 0.9). In 1995, the highest and the lowest age-standardized incidence rates (per 10(5)) were 15.2 in Denmark and 2.1 in Lithuania. Incidence rates (i.e., for all cancers and for seminomas and nonseminomas, separately) depended chiefly on birth cohort rather than on calendar period of diagnosis (although both birth cohort and period determined the Danish incidence rates).
CONCLUSIONS: Testicular cancer incidence is still increasing, with the exception of Denmark, and a large geographic difference exists. The increasing trend is mainly a birth cohort phenomenon also in recent cohorts. Temporal trends for seminomas and nonseminomas are similar, which suggests that they share important causal factors.

Entities:  

Mesh:

Year:  2004        PMID: 15598775

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

Review 1.  Gene-environment interaction and male reproductive function.

Authors:  Jonatan Axelsson; Jens Peter Bonde; Yvonne L Giwercman; Lars Rylander; Aleksander Giwercman
Journal:  Asian J Androl       Date:  2010-03-29       Impact factor: 3.285

Review 2.  Conditions in utero and cancer risk.

Authors:  Tom Grotmol; Elisabete Weiderpass; Steinar Tretli
Journal:  Eur J Epidemiol       Date:  2006-09-13       Impact factor: 8.082

3.  Gestational age at birth and risk of testicular cancer.

Authors:  Casey Crump; Kristina Sundquist; Marilyn A Winkleby; Weiva Sieh; Jan Sundquist
Journal:  Int J Cancer       Date:  2011-09-14       Impact factor: 7.396

4. 

Authors:  Peter T K Chan
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

5.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

Review 6.  Falling sperm counts twenty years on: where are we now?

Authors:  R John Aitken
Journal:  Asian J Androl       Date:  2013-01-28       Impact factor: 3.285

7.  International trends in the incidence of testicular cancer, 1973-2002.

Authors:  Victoria M Chia; Sabah M Quraishi; Susan S Devesa; Mark P Purdue; Michael B Cook; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

8.  Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006.

Authors:  Jenny N Poynter; James F Amatruda; Julie A Ross
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

Review 9.  [Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders].

Authors:  J Oldenburg; S D Fosså
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

Review 10.  Decreasing sperm quality: a global problem?

Authors:  Hiltrud Merzenich; Hajo Zeeb; Maria Blettner
Journal:  BMC Public Health       Date:  2010-01-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.